Cartesian Therapeutics develops mRNA cell therapies for autoimmune diseases, leveraging three modalities: mRNA CAR-T, mRNA MSC, and mRNA in situ. Lead asset Descartes-08 targets myasthenia gravis, ...

Find out all the key statistics for Cartesian Therapeutics, Inc. (RNAC), including valuation measures, fiscal year financial statistics, trading record, share statistics and more.

Cartesian's mRNA-based cell therapy offers a novel, outpatient approach for autoimmune diseases, eliminating the need for preconditioning chemotherapy. Lead candidate Descartes-08 showed promising ...

Find out all the key statistics for Cartesian Growth Corporation II (RENEF), including valuation measures, fiscal year financial statistics, trading record, share statistics and more.

Construct financial models with decades of earnings statistics, ratios and valuation data - all exportable - to drive your trade ideas.

Moving an object from one location to another—picking and placing—is an ideal application for industrial robots due to the robots’ repeatability, throughput and favorable return on investment. It is ...